CLEC9A，也称为DNGR1，被定义为具有单个细胞外C型凝集素结构域的II型膜蛋白。CLEC9A参与感染过程中的适应性免疫反应。此外，CLEC9A正在研究增强疫苗产生的免疫应答的潜力。 抗小鼠CD 370（1F 6）体内抗体-超低内毒素该产品同种型对照：Rat IgG1 Isotype Control for In Vivo - Low Endotoxin [GL113] (ICH2246) 缓冲液：ICH3001-100ml，nICH3002-100ml，nICH3003-100ml， 浓度：>2.0 mg/ml 纯度：>98% by SDS-PAGE and HPLC 内毒素：≤ 0.5 EU/mg as determined by the LAL method 制剂：This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (PBS) pH 7.2 – 7.4, 150 mM NaCl with no carrier protein, potassium or preservatives added. BSA and azide free
应用类型
Flow Cytometry, Immunofluorescence, Western Blot
免疫原
RBL-2H3 cells expressing mouse DNGR-1 fused to an HA epitope.
